• October 22, 2013
    From the cows that provide the milk for a bowl of cereal to the deer nibbling on a shrub in the park, from sea lions working with their trainers at the zoo to puppies chasing balls in the yard, the connections humans have with animals are vast. This special relationship is explored in a new mobile exhibit from the Smithsonian.“Animal Connections: Our Journey Together,” a custom-built exhibition housed on an 18-wheel truck that expands into 1,000 square feet of space, will be on view on themore...
  • October 1, 2013
    FLORHAM PARK, N.J., October 1, 2013 – Zoetis Inc., (NYSE: ZTS) formerly the animal health business unit of Pfizer Inc., has notified the U.S. Food and Drug Administration (FDA) that the company will voluntarily withdraw the marketing authorizations (New Animal Drug Applications) for 3-Nitro (roxarsone)  and Carb-O-Sep ® (carbarsone). The decision to withdraw the marketing authorization for 3-Nitro, a feed medicine containing the organic arsenical roxarsone, follows the suspension ofmore...
  • September 30, 2013
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS), formerly the animal health business unit of Pfizer Inc., will host a webcast and conference call at 8:30 a.m. (EST) on Tuesday, Nov. 5, 2013. Chief Executive Officer Juan Ramón Alaix and Executive Vice President and Chief Financial Officer Rick Passov will review third-quarter 2013 financial results, discuss 2013 financial guidance, and respond to questions from financial analysts during the call.more...
  • September 19, 2013
    FLORHAM PARK, N.J. – September 19, 2013 – Zoetis, Inc. (NYSE: ZTS), formerly the animal health business unit of Pfizer Inc., today announced that following a positive opinion from the Committee for Medicinal Products for Veterinary Use (CVMP), the European Commission has approved APOQUEL® (oclacitinib tablet) in the European Union for the treatment of pruritus associated with allergic dermatitis and the treatment of clinical manifestations of atopic dermatitis in dogs at least 12 months of agemore...
  • September 16, 2013
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE: ZTS), formerly the animal health business unit of Pfizer Inc., today celebrated establishing strong roots in New Jersey by hosting New Jersey Governor Chris Christie for an address to employees at the company’s new world headquarters in Florham Park, N.J. Governor Christie joined members of the Zoetis Executive Team to plant a Red Oak, the New Jersey state tree, helping replace trees lost to Super Storm Sandymore...
  • September 12, 2013
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--The Board of Directors of Zoetis Inc. (NYSE:ZTS), formerly the animal health business of Pfizer Inc., has declared a fourth-quarter dividend payable to holders of the company’s common stock of $0.065 per share. The dividend is to be paid on Dec. 2, 2013, to holders of record on Nov. 1, 2013. About Zoetis Zoetis (zō-EH-tis) is the leading animal health company, dedicated to supporting its customers and theirmore...
  • August 16, 2013
    NEWARK, N.J. August 16, 2013 —From the cows that provide the milk for a bowl of cereal to the deer nibbling on a shrub in the park, from sea lions working with their trainers at the zoo to puppies chasing balls in the yard, the connections humans have with animals are vast. This special relationship is explored in a new mobile exhibition from the Smithsonian.“Animal Connections: Our Journey Together,” a custom-built exhibition housed on an 18-wheel truck that expands into 1,000 square feet ofmore...
  • August 6, 2013
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE: ZTS), a former business unit of Pfizer Inc., today reported its financial results for the second quarter of 2013. The company reported revenue of $1.11 billion for the second quarter, an increase of 2% from the second quarter of 2012. Revenue reflected an operational2 increase of 4%, with foreign currency having a negative impact of 2 percentage points. Net income for the second quarter of 2013 was $128 million, or $0more...
  • August 4, 2013
    HUINAN, JILIN, China--(BUSINESS WIRE)--Zoetis today announced that its joint venture in China received the approval by the Ministry of Agriculture of the People’s Republic of China for Rui Lan An™, a specialized vaccine to help control the highly pathogenic porcine reproductive and respiratory syndrome (HP PRRS). Rui Lan An, which will be launched later this month, is the first vaccine to emerge from the joint venture that was established to develop and manufacture animal vaccinesmore...
  • August 1, 2013
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE: ZTS), a former business unit of Pfizer Inc., today announced the appointment of Louise M. Parent, Executive Vice President and General Counsel of American Express Company, to its Board of Directors. Ms. Parent will serve on the Compensation Committee of the Board. Ms. Parent has deep experience in corporate governance and board matters, gained during her tenure with American Express, where she works extensivelymore...